BETA-2 MICROGLOBULIN: A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF HUMAN PROSTATE CANCER BONE METASTASIS

$572,254FY2008Department of DefenseDOD

Cedars-Sinai Medical Center, West Hollywood CA

Investigators